EUVIMEDEUVIMED entdecken
Open Access

Upregulation of delta opioid receptor by meningeal interleukin-10 prevents relapsing pain

Kufreobong E Inyang, Jaewon Sim, Kimberly B Clark, Matan Geron, Karli Monahan, Christine Evans, Patrick O'Connell, Sophie Laumet, Bo Peng, Jiacheng Ma, Cobi J Heijnen, Robert Dantzer und 7 weitere

Brain, Behavior, and Immunity · 2025-01 · 123 · 399-410

DOI: 10.1016/j.bbi.2024.09.031 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain, Behavior, and Immunity, 2025-01. Verfasst von Kufreobong E Inyang und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, Michigan State University, East Lansing, MI, USA. Hauptthemen laut MEDLINE: Interleukin-10, Receptors, Opioid, delta, Meninges, Ganglia, Spinal. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDA NIH HHS, NINDS NIH HHS, National Institute on Drug Abuse.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic pain often includes periods of transient amelioration and even remission that alternate with severe relapsing pain. While most research on chronic pain has focused on pain development and maintenance, there is a critical unmet need to better understand the mechanisms that underlie pain remission and relapse. We found that interleukin (IL)-10, a pain resolving cytokine, is produced by resident macrophages in the spinal meninges during remission from pain and signaled to IL-10 receptor-expressing sensory neurons. Using unbiased RNA-sequencing, we identified that IL-10 upregulated expression and antinociceptive activity of δ-opioid receptor (δOR) in the dorsal root ganglion. Genetic or pharmacological inhibition of either IL-10 signaling or δOR triggered relapsing pain. Overall, our findings, from electrophysiology, genetic manipulation, flow cytometry, pharmacology, and behavioral approaches, indicate that remission of pain is not simply a return to the naïve state. Instead, remission is an adapted homeostatic state associated with lasting pain vulnerability resulting from persisting neuroimmune interactions within the nociceptive system. Broadly, this sheds light on the elusive mechanisms underlying recurrence a common aspect across various chronic pain conditions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Interleukin-10Receptors, Opioid, deltaMeningesGanglia, SpinalUp-RegulationAnimalsMiceMaleMice, Inbred C57BLRecurrenceChronic PainMacrophagesSensory Receptor CellsReceptors, Interleukin-10

Substanzen

Interleukin-10Receptors, Opioid, deltaReceptors, Interleukin-10

Autor:innen und Institutionen

  • Department of Physiology, Michigan State University, East Lansing, MI, USA.
  • Department of Physiology, Michigan State University, East Lansing, MI, USA; Cell and Molecular Biology Graduate Program, Michigan State University, East Lansing, MI, USA.
  • Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Department of Cell Biology and Physiology, Department of Pharmacology, UNC Neuroscience Center, University of North Carolina, Chapel Hill, NC, USA.
  • Department of Microbiology and Molecular Genetics, Michigan State University, East Lansing, MI, USA.
  • Department of Cell Biology and Physiology, Department of Pharmacology, UNC Neuroscience Center, University of North Carolina, Chapel Hill, NC, USA; New York Stem Cell Foundation - Robertson Investigator, University of N…

Förderung

  • NIDA NIH HHS
  • NINDS NIH HHS
  • National Institute on Drug Abuse
  • National Institute of Neurological Disorders and Stroke
  • American Pain Society
  • Rita Allen Foundation
  • US Department of Defense
  • National Institutes of Health

Zitieren

APA

Inyang, K. E., Sim, J., Clark, K. B., Geron, M., Monahan, K., Evans, C., O'Connell, P., Laumet, S., Peng, B., Ma, J., Heijnen, C. J., Dantzer, R., Scherrer, G., Kavelaars, A., Bernard, M., Aldhamen, Y. A., Folger, J. K., Bavencoffe, A., & Laumet, G. (2025). Upregulation of delta opioid receptor by meningeal interleukin-10 prevents relapsing pain. Brain, Behavior, and Immunity, 123, 399-410. https://doi.org/10.1016/j.bbi.2024.09.031

Vancouver

Inyang KE, Sim J, Clark KB, Geron M, Monahan K, Evans C, et al. Upregulation of delta opioid receptor by meningeal interleukin-10 prevents relapsing pain. Brain, Behavior, and Immunity. 2025;123:399-410. doi:10.1016/j.bbi.2024.09.031

BibTeX
@article{Inyang2025,
  author = {Inyang, Kufreobong E and Sim, Jaewon and Clark, Kimberly B and Geron, Matan and Monahan, Karli and Evans, Christine and O'Connell, Patrick and Laumet, Sophie and Peng, Bo and Ma, Jiacheng and Heijnen, Cobi J and Dantzer, Robert and Scherrer, Grégory and Kavelaars, Annemieke and Bernard, Matthew and Aldhamen, Yasser A and Folger, Joseph K and Bavencoffe, Alexis and Laumet, Geoffroy},
  title = {Upregulation of delta opioid receptor by meningeal interleukin-10 prevents relapsing pain},
  journal = {Brain, Behavior, and Immunity},
  year = {2025},
  volume = {123},
  pages = {399--410},
  doi = {10.1016/j.bbi.2024.09.031}
}
Kostenlos starten →